National HealthCare Corporation (NHC)
NYSEAMERICAN: NHC · Real-Time Price · USD
233.40
-3.35 (-1.41%)
Aug 21, 2026, 4:00 PM EDT - Market closed
National HealthCare Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,655 | 2,127 | 1,661 | 1,416 | 913 | 1,048 | |
Market Cap Growth | 114.62% | 28.07% | 17.27% | 55.13% | -12.87% | 2.73% |
Enterprise Value | 3,477 | 1,963 | 1,646 | 1,310 | 874 | 973 |
Last Close Price | 233.40 | 136.11 | 104.42 | 87.72 | 54.53 | 60.21 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.22 | 17.72 | 16.29 | 21.20 | 40.68 | 7.56 |
Forward PE | - | 17.52 | 17.52 | 17.52 | 17.52 | 17.52 |
PS Ratio | 2.34 | 1.40 | 1.28 | 1.25 | 0.85 | 1.04 |
PB Ratio | 3.26 | 1.98 | 1.69 | 1.56 | 1.04 | 1.15 |
P/TBV Ratio | 3.92 | 2.42 | 2.10 | 1.93 | 1.31 | 1.44 |
P/FCF Ratio | 24.95 | 14.31 | 20.84 | 17.00 | - | 45.57 |
P/OCF Ratio | 19.36 | 11.49 | 15.48 | 12.74 | 104.44 | 16.79 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.23 | 1.29 | 1.27 | 1.15 | 0.81 | 0.96 |
EV/EBITDA Ratio | 18.26 | 11.33 | 13.44 | 14.04 | 15.13 | 26.09 |
EV/EBIT Ratio | 24.03 | 15.29 | 20.46 | 25.56 | 50.59 | - |
EV/FCF Ratio | 23.73 | 13.21 | 20.65 | 15.72 | - | 42.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.08 | 0.22 | 0.10 | 0.14 | 0.18 |
Debt / EBITDA Ratio | 0.13 | 0.40 | 1.30 | 0.69 | 1.28 | 2.13 |
Debt / FCF Ratio | 0.21 | 0.59 | 2.70 | 1.12 | - | 7.25 |
Net Debt / Equity Ratio | -0.16 | -0.16 | 0.00 | -0.14 | -0.06 | -0.10 |
Net Debt / EBITDA Ratio | -0.94 | -0.97 | -0.01 | -1.40 | -0.98 | -2.40 |
Net Debt / FCF Ratio | -1.22 | -1.13 | -0.02 | -1.56 | 2.64 | -3.89 |
Asset Turnover | 1.01 | 1.00 | 0.92 | 0.88 | 0.80 | 0.73 |
Inventory Turnover | 114.85 | 109.43 | 98.74 | 98.43 | 87.58 | 76.72 |
Quick Ratio | 1.47 | 1.56 | 1.50 | 1.55 | 1.43 | 1.34 |
Current Ratio | 1.86 | 1.82 | 1.81 | 1.89 | 1.79 | 1.62 |
Return on Equity (ROE) | 13.27% | 11.92% | 10.78% | 7.30% | 2.24% | 16.30% |
Return on Assets (ROA) | 5.84% | 5.26% | 3.55% | 2.48% | 0.81% | -0.15% |
Return on Invested Capital (ROIC) | 12.21% | 10.27% | 6.83% | 4.71% | 1.54% | -0.42% |
Return on Capital Employed (ROCE) | 11.10% | 10.10% | 6.20% | 4.70% | 1.60% | -0.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.84% | 5.64% | 6.14% | 4.72% | 2.46% | 13.23% |
FCF Yield | 4.01% | 6.99% | 4.80% | 5.88% | -2.35% | 2.19% |
Dividend Yield | 1.15% | 1.86% | 2.32% | 2.67% | 4.14% | 3.50% |
Payout Ratio | 30.11% | 32.25% | 36.27% | 53.23% | 154.17% | 23.11% |
Buyback Yield / Dilution | -0.86% | -0.31% | -1.44% | 0.45% | -0.20% | -0.31% |
Total Shareholder Return | 0.29% | 1.55% | 0.88% | 3.12% | 3.95% | 3.20% |